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Welcome to the 16th Annual Conference of the Society
on NeuroImmune Pharmacology
We are pleased to publish the abstracts from this Confer-
ence in the Journal of Neuroimmune Pharmacology. We are
most pleased that Springer has agreed to provide these
abstracts in open access; this is the first time the abstracts
from our Conference will be published in their entirety. The
Society on NeuroImmune Pharmacology recognizes the
continued support of Dr. Howard Gendelman and Robin
Taylor, our chief and managing editors, and Ann Avouris,
Springer US, in seeing this process to fruition.
This year’s conference—April 14–17, 2010, at the
Manhattan Beach Marriott Hotel, Manhattan Beach, CA,
USA—will maintain a focus on drugs of abuse in
modulating neuroimmune processes and on HIV infection.
A major objective of the conference is to support young
investigators. The “highlight” event will be the Young
Investigator Poster Session followed by a “Meet the Mentors”
buffet at which young investigators will interact with senior
investigators fromacademia, the NationalInstitutes of Health,
and industry to discuss career opportunities. In addition, a
General Poster Session will be held. Abstracts of the 16th
Annual Meeting of the Society will be published in the
Journal of Neuroimmune Pharmacology.
TwoPlenaryLectureswillbepresented.Thefirstwillbeby
Stuart Lipton, M.D., Ph.D., Scientific Director of the Burn-
ham Center for Neuroscience, Aging, and Stem Cell
Research. The second Plenary Lecture will be presented by
Vincenzo Di Marzo, from the Istituto di Chimica Biomoleco-
lare Nazionale delle Ricerche, Pozzuoli, Italy. Dr. DiMarzo
will provide a general introduction on endocannabinoids and
related lipid mediators and their emerging role in neuro-
inflammatory disorders. There also will be four symposia on
HIV-relatedand DrugAbuse-related topics: “Effects ofHIV-1
in Promoting Alcohol Addiction and Mechanisms of Associ-
ated Neurodegeneration”; “Opiates, Other Drugs of Abuse
andCo-Infections”; “Epigenomic RegulationinNeuroscience
and HIV Infection”; and a Special Thursday Evening
Symposium hosted by the UCLA Center for AIDS Research
and the UCLA AIDS Institute entitled “HIV and Host
Immunity in the Design of Novel Therapeutic Approaches.”
This Special Evening Symposium will address interventional
therapies and translational research related to HIV and its
pathogenesis. In addition, there will be a symposium that will
address the issue of tobacco and nicotine entitled “The News
About Tobacco Smoke Is Worse than You Think” and a
symposium on “Neuroimmunopharmacology and the Canna-
binoid System.” The major symposium lecture for the
symposium on tobacco and nicotine will be presented by
Nancy Kerkvliet, Ph.D., Professor of Environmental and
Molecular ToxicologyatOregonStateUniversity.A highlight
symposium will address “Nanomedicine and Drug Delivery.”
The symposium lecture for this session will be presented by
Andre Nel, Ph.D., Chief, Division of Nanomedicine at the
UCLA Geffen School of Medicine.
There will be a Young Investigator’s Symposium
sponsored by the SNIP Young Investigator Travel Award
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ers two postdoctoral and two predoctoral speakers from the
pool of submitted Young Investigator abstracts. In addition,
there will be a Luncheon Technical Workshop sponsored by
the National Institute on Drug Abuse and the National
Institute on Alcohol Abuse and Alcoholism that will
address new initiatives at the National Institutes of Health,
Grant Writing, and the Grant Review Process. A final
highlight presentation will be the Saturday evening Banquet
Lecture that will be given by Patricia Molina, M.D., Ph.D.,
from the Louisiana State University Health Science Center
in New Orleans.
The Manhattan Beach Marriott Hotel conference site is
conveniently located 3 miles south of Los Angeles Interna-
tional Airport (LAX) anda mile anda halffrom thevillageof
Manhattan Beach. Manhattan Beach is a funky ocean town
with surfing, sunning on the beach, eating in small local
restaurants, and walking the sand dunes.
Los Angles boasts an array of things to do—golfing at
the hotel on an executive size course (all holes less than
175 yards), touring Hollywood, “beaching it,” sitting in the
audience for the Jay Leno show, or munching wood-burned
pizza at Spagos. The Meetings Committee has left Friday
afternoon open to allow conference participants to indulge
whatever fantasies they may have regarding the “City of the
Angels.” One possibility would be to join a group of
attendees on a trip to the Getty Museum—one of the great
new museums in the country. It is possible to spend the
afternoon wandering around the spectacular grounds hous-
ing the collections.
We thank the Carol Swarts Emerging Neuroscience
Laboratory, University of Nebraska Medical Center; the
Society on NeuroImmune Pharmacology; and Springer for
their support in publishing this abstract book.
Again, welcome to the 16th Annual Conference of the
Society on NeuroImmune Pharmacology.
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